201 related articles for article (PubMed ID: 29872961)
1. Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.
Rajamanikam A; Kumar S; Samudi C; Kudva M
Parasitol Res; 2018 Aug; 117(8):2585-2590. PubMed ID: 29872961
[TBL] [Abstract][Full Text] [Related]
2. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms.
Vogelberg C; Stensvold CR; Monecke S; Ditzen A; Stopsack K; Heinrich-Gräfe U; Pöhlmann C
Parasitol Int; 2010 Sep; 59(3):469-71. PubMed ID: 20363362
[TBL] [Abstract][Full Text] [Related]
3. Blastocystis: to treat or not to treat..
Coyle CM; Varughese J; Weiss LM; Tanowitz HB
Clin Infect Dis; 2012 Jan; 54(1):105-10. PubMed ID: 22075794
[TBL] [Abstract][Full Text] [Related]
4. [Blastocystis--an enigmatic parasite].
Stensvold CR; Arendrup MC; Nielsen HV; Mølbak K
Ugeskr Laeger; 2009 Aug; 171(34):2388-90. PubMed ID: 19732521
[TBL] [Abstract][Full Text] [Related]
5. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.
Raman K; Kumar S; Chye TT
Parasitol Res; 2016 Jan; 115(1):391-6. PubMed ID: 26481491
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity of Blastocystis hominis, a clinical reevaluation.
Kaya S; Cetin ES; Aridoğan BC; Arikan S; Demirci M
Turkiye Parazitol Derg; 2007; 31(3):184-7. PubMed ID: 17918055
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain.
Salvador F; Sulleiro E; Sánchez-Montalvá A; Alonso C; Santos J; Fuentes I; Molina I
Parasit Vectors; 2016 Oct; 9(1):548. PubMed ID: 27741951
[TBL] [Abstract][Full Text] [Related]
8. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Cobuccio LG; Laurent M; Gardiol C; Wampfler R; Poppert S; Senn N; Eperon G; Genton B; Locatelli I; de Vallière S
J Travel Med; 2023 Feb; 30(1):. PubMed ID: 36440639
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.
Dinleyici EC; Eren M; Dogan N; Reyhanioglu S; Yargic ZA; Vandenplas Y
Parasitol Res; 2011 Mar; 108(3):541-5. PubMed ID: 20922415
[TBL] [Abstract][Full Text] [Related]
10. Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.
Rajamanikam A; Hooi HS; Kudva M; Samudi C; Kumar S
PLoS One; 2019; 14(2):e0212542. PubMed ID: 30794628
[TBL] [Abstract][Full Text] [Related]
11. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole.
Moghaddam DD; Ghadirian E; Azami M
Parasitol Res; 2005 Jun; 96(4):273-5. PubMed ID: 15915364
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Blastocystis carriage with antimicrobials: reality or delusion?
Stensvold CR; Smith HV; Nagel R; Olsen KE; Traub RJ
J Clin Gastroenterol; 2010 Feb; 44(2):85-90. PubMed ID: 19834337
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.
Nigro L; Larocca L; Massarelli L; Patamia I; Minniti S; Palermo F; Cacopardo B
J Travel Med; 2003; 10(2):128-30. PubMed ID: 12650658
[TBL] [Abstract][Full Text] [Related]
14. Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review.
Batista L; Pérez Jove J; Rosinach M; Gonzalo V; Sainz E; Loras C; Forné M; Esteve M; Fernández-Bañares F
Gastroenterol Hepatol; 2017; 40(6):381-387. PubMed ID: 28279442
[TBL] [Abstract][Full Text] [Related]
15. Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy.
Nagel R; Cuttell L; Stensvold CR; Mills PC; Bielefeldt-Ohmann H; Traub RJ
Intern Med J; 2012 Nov; 42(11):1187-95. PubMed ID: 22032439
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in Blastocystis spp. is related to subtype.
Dhurga DB; Suresh KG; Tan TC; Chandramathi S
Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):725-30. PubMed ID: 23141370
[TBL] [Abstract][Full Text] [Related]
17. Blastocystis sp., Parasite Associated with Gastrointestinal Disorders: An Overview of its Pathogenesis, Immune Modulation and Therapeutic Strategies.
Kumarasamy V; Anbazhagan D; Subramaniyan V; Vellasamy S
Curr Pharm Des; 2018; 24(27):3172-3175. PubMed ID: 30084327
[TBL] [Abstract][Full Text] [Related]
18. Is paromomycin the drug of choice for eradication of Blastocystis in adults?
van Hellemond JJ; Molhoek N; Koelewijn R; Wismans PJ; van Genderen PJ
J Infect Chemother; 2013 Jun; 19(3):545-8. PubMed ID: 23053509
[TBL] [Abstract][Full Text] [Related]
19. Blastocystis hominis: evidence for human pathogenicity and effectiveness of metronidazole therapy.
Guirges SY; Al-Waili NS
Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):333-5. PubMed ID: 3665198
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of Blastocystis infections in Turkey.
Ozyurt M; Kurt O; Mølbak K; Nielsen HV; Haznedaroglu T; Stensvold CR
Parasitol Int; 2008 Sep; 57(3):300-6. PubMed ID: 18337161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]